Literature DB >> 2149101

What does protein binding of radiopharmaceuticals mean exactly?

O Jeghers, A Piepsz, H R Ham.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2149101     DOI： 10.1007/bf00811433

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  8 in total

1.  Why do Tc-99m chelates work for cholescintigraphy?

Authors:  G Firnau
Journal:  Eur J Nucl Med       Date:  1976-08-12

2.  Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.

Authors:  J R Coveney; M S Robbins
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

3.  Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.

Authors:  A Taylor; D Eshima; P E Christian; W W Wooten; L Hansen; K McElvany
Journal:  J Nucl Med       Date:  1988-05       Impact factor: 10.057

4.  Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.

Authors:  R A Jafri; K E Britton; C C Nimmon; K Solanki; A Al-Nahhas; J Bomanji; J Fettich; L A Hawkins
Journal:  J Nucl Med       Date:  1988-02       Impact factor: 10.057

5.  2,3-Dimercaptosuccinic-acid chelates--2. Renal localization.

Authors:  J L Moretti; J R Rapin; J C Saccavini; A Lageron; M Le Poncin; A Bardy
Journal:  Int J Nucl Med Biol       Date:  1984

6.  Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.

Authors:  C Schümichen; K Koch; A Kraus; G Kuhlicke; K Weiler; A Wenn; G Hoffman
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

7.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Authors:  A R Fritzberg; S Kasina; D Eshima; D L Johnson
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

8.  Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV. Interaction of 99mTc-DMS and 99Tc-DMS complexes with blood serum proteins.

Authors:  N Vanlić-Razumenic; J Petrovic; D Gorkic
Journal:  Eur J Nucl Med       Date:  1984
  8 in total
  2 in total

Review 1.  Quantification of renal haemodynamics with radionuclides.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.